Menu
The Galien Foundation
medal
Join us
    The Galien Foundation
      Prix Galien Medal
      Join us
      Prix Galien Coin
      Join us
      Join us
      What is happening
      Galien Image
      Prix Galien Korea

      Seoul Sep. 10

      Galien Image
      Prix Galien USA

      New York City Oct. 29

      Galien Image
      Prix Galien Bridges

      Stockholm Dec. 01

        Community
        Mission Partnership
        Recognition & Celebration
        Prix Galien International Galien Golden Jubliee Juries worldwide Prix Galien USA Roy Vagelos Pro Bono Humanum Award Prix Galien EcoHealth Prix Galien Bridges
        Prix Galien in the world Laureates Private sector since 1970 Pro Bono awards & Laureates Academic and Public sector since 1970 History of the Prize
        Education
        Galien Patient Summit Galien Week of Innovation Galien Forum USA Galien Forum Africa Galien Webinar Series Jerusalem Ethics Forum Top scientists & KOL Jury members worldwide
        Fueling the Debate
        Press releases Notable events Media Kit
        Submit your innovation
        Event Tickets
        Signup to our newsletter
        Contact
        Privacy Policy
        Terms of Service

        2025 Prix Galien Bridges Laureates

        The inaugural Prix Galien Bridges yielded an impressive millesime.

        dropdown-iconBest Bridge-Builder Institution

        Coalition for Epidemic Preparedness Innovations (CEPI)

        dropdown-iconBest Biotech & Pharma Product

        QUVIVIQ - Idorsia Pharmaceuticals Nordics AB

        dropdown-iconBest Medical Technology / AI Advances in Human Health

        AI-Immunology™ platform - Evaxion

        dropdown-iconBest Product for Rare/Orphan Diseases

        VORANIGO® - Servier Pharmaceuticals

        dropdown-iconBest Public Sector Innovation

        MenAfriVac - PATH

        Through the “Bridges” initiative, Prix Galien leverages its convening power to build and strengthen relationships that showcase the Nordic1 region’s long history of creative, integrated approaches to maximizing its reach and market potential in the larger regional/global biopharmaceutical and adjacent technology sectors.

        Best Bridge-Builder 2025
        Best Bridge-Builder Institution 2025 
        Best BioPharma 2025
        Best Biotech & Pharma Product 2025 
        Best MedtechAI 2025
        Best Medical Technology/AI Advances 2025 
        Best RareOrphan 2025
        Best Product for Rare/Orphan Diseases 2025 
        Best Public Sector Innovation 2025
        Best Public Sector Innovation 2025 

        2025 «True North» Award

        In addition to our competitive award categories for innovation and institutional excellence, Bridges features a special individual honor: The Bengt I. Samuelsson «True North» Award for scientific integrity.

        This award recognizes scientists who pursue research with exceptional ethical rigor, intellectual honesty, and commitment to advancing knowledge without fanfare or self-promotion. The «True North» designation reflects the moral compass and unwavering scientific standards that guide the best research toward meaningful impact on human health. 

        The 2025 Bengt I. Samuelsson "True North" Award for Scientific Integrity was presented to Jesper Z Haeggström, MD, PhD, Head of Division Chemistry II at the Karolinska Institutet’s Department of Medical Biochemistry and Biophysics in recognition of his commitment to ethical rigor, intellectual honesty, mentorship in is advancement of science.

        True North Award 2025 -3
        Karin Samulesson
        True North Award 2025 -2
        Jesper Z Haeggström, MD, PhD

        An illustrious committee of industry leaders
        Judges of the Prix Galien Bridges Awards are among the industry’s brightest luminaries from their respective countries. Respected globally, we are particularly excited to bring them together for the Prix Galien Bridges Awards where we anticipate particularly meaningful exchange through the prism of the geographical bridge they represent.

        Maria Alonso Image
        Professor of Pharmaceutical Technology, University of Santiago de Compostela
        María José ALONSO, MD, PhD
        Alon Chen Image
        President, Weizmann Institute of Science
        Alon CHEN, PhD
        Mikael Dolsten Photo
        Chair, Prix Galien Bridges Committee; Chairman, Quarry Thera (founding CEO), Orbis Medicine, Orogen Therapeutics, and Mast Cell Sciences Board member, Agilent Technologies, Rocket Pharmaceuticals, Chai Discovery, BenchSci, and Enveda Biosciences
        Mikael DOLSTEN, MD, PhD
        Emma Guttman Image
        Chair, Kimberly & Eric J. Waldman Department of Dermatology, Icahn School of Medicine at Mount Sinai
        Emma GUTTMAN-YASSKY, MD, PhD
        Mirza Mansoor photo
        Medical Director, Nordic Society of Gynaecologic Oncology-Clinical Trial Unit
        Mansoor MIRZA, MD
        Aarno Palotie Photo
        Research Director of Human Genomics, Institute for Molecular Medicine Finland
        Aarno PALOTIE, MD, PhD
        Erik Renstrom Photo
        Vice Chancellor, Lund University
        Erik RENSTRÖM, PhD
        John Arne Rottingen photo
        CEO, Wellcome
        John-Arne RØTTINGEN, MD, PhD
        Veronika Sexl photo
        Rector, University of Innsbruck
        Veronika SEXL, MD, PhD
        Kári Stefánsson Photo
        CEO, deCODE genetics
        Kári STEFANSSON, MD, PhD
        Carl Johan SUNDBERG
        Professor & Dean, Karolinska Institutet Nord
        Carl Johan SUNDBERG, MD, PhD

        Through a set of prestigious annual awards, unique, internal stakeholder dialogue, public events, and persuasive published research and communications, we will help make the case for innovative biopharma science as a driver of balanced development and for the transformative knowledge and business practices that add to quality of life for patients and more efficient use of scarce health resources. We recognize the importance of leveraging these strengths to enhance the science base in selected small and middle-sized markets that have yet to secure their potential in attracting the scalable investments necessary to bring new cures and treatments to a wider circle of patients.

        Michael Dolsten

        Prix Galien Bridges Committee Chair, Mikael Dosten at the Inaugural Awards Ceremony

        We deliberately use the term “Bridges” given our aim to – through this initiative - facilitate expertise and knowledge transfers around the Nordic region’s innovation precedents and best practices with five additional strategic countries (comprising the plus in Nordics+): Austria, Israel, The Netherlands, Portugal, and Spain. Countries in the region with existing, active Prix Galien programs – Belgium, France, Germany, Greece, and Italy – have pledged their collaboration and solidarity.

        Certain part of the world highlighting country in red colors

        1 The Nordic countries are a geographical and cultural region in Northern Europe and the North Atlantic. It includes the sovereign states of Denmark, Finland, Iceland, Norway and Sweden; the autonomous territories of the Faroe Islands and Greenland; and the autonomous region of Åland.

        Group 1035
        Prix Galien Bridges Charter
        Globe
        Prix Galien in the World
        Group 1037
        Worldwide Committees
        Group 1033
        FAQ
        Contact Us
        PRIX GALIEN HALL OF FAME
        Search the innovations that have made the greatest impact on human health over the course of the past 50 years worldwide.